Golden
Codiak BioSciences

Codiak BioSciences

Codiak Biosciences is a biotechnology company developing exosome therapeutics.

All edits

Edits on 19 Mar 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 19 Mar 2019 6:24 pm
Edits made to:
Article (+21/-21 characters)

Article

On November 17, 2015 Codiak BioSciences completed their series A funding round with $31 million in capital from Flagship Pioneering, ARCH Venture PartnersARCH Venture Partners, and Fidelity Management and Research Company. 

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 19 Mar 2019 6:17 pm
Edits made to:
Article (+26/-26 characters)

Article

On November 27, 2017 Codiak BioSciences completed their series C funding round with $76.5 million in capital from Sirona Capital, Qatar Investment AuthorityQatar Investment Authority, Flagship Pioneering, Fidelity Management and Research Company. 

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 19 Mar 2019 6:15 pm
Edits made to:
Article (+21/-21 characters)

Article

On January 26, 2016 Codiak BioSciences completed their series B funding round with $61 million in capital from Flagship Pioneering (lead investor), ARCH Venture Partners (lead investor), Alexandria Venture, and Alaska Permanent FundAlaska Permanent Fund. 

Dawson Sewell
Dawson Sewell edited on 19 Mar 2019 4:01 pm
Edits made to:
Infobox (+11 properties)
Timeline (+3 events) (+726 characters)
Description (+79 characters)
Article (+878 characters)
Further reading (+12 cells) (+791 characters)
Categories (+1 topics)
Related Topics (+2 topics)
Topic thumbnail

Codiak BioSciences

Codiak Biosciences is a biotechnology company developing exosome therapeutics.

Article

Codiak Biosciences is a biotechnology company developing exosome therapeutics that is headquartered in Cambridge, Massachusetts and was founded by Eric lander and Raghu Kalluri in 2015.

Funding

Series A

On November 17, 2015 Codiak BioSciences completed their series A funding round with $31 million in capital from Flagship Pioneering, ARCH Venture Partners, and Fidelity Management and Research Company. 

Series B

On January 26, 2016 Codiak BioSciences completed their series B funding round with $61 million in capital from Flagship Pioneering (lead investor), ARCH Venture Partners (lead investor), Alexandria Venture, and Alaska Permanent Fund. 

Series C

On November 27, 2017 Codiak BioSciences completed their series C funding round with $76.5 million in capital from Sirona Capital, Qatar Investment Authority, Flagship Pioneering, Fidelity Management and Research Company. 

Further reading

Title
Author
Link
Type

Codiak BioSciences Presents First Data on exoSTING - A Novel Engineered Exosome Therapeutic Targeting Checkpoint Refractory Tumors at the Society for Immunotherapy of Cancer's 33rd Annual Meeting

Codiak BioSciences, Inc.

Web

What You Need to Know About Codiak BioSciences

Mark Terry

Web

Xconomy: VCs Put More Dollars Into Exosomes as Codiak Bio Lands $76M

Ben Fidler

Web

Infobox

Categories

Related Topics

Timeline

November 27, 2017

Series C funding round

On November 27, 2017 Codiak BioSciences completed their series C funding round with $76.5 million in capital from Sirona Capital, Qatar Investment Authority, Flagship Pioneering, Fidelity Management and Research Company. 

January 26, 2016

Series B funding round

On January 26, 2016 Codiak BioSciences completed their series B funding round with $61 million in capital from Flagship Pioneering (lead investor), ARCH Venture Partners (lead investor), Alexandria Venture, and Alaska Permanent Fund. 

November 17, 2015

Series A funding round

On November 17, 2015 Codiak BioSciences completed their series A funding round with $31 million in capital from Flagship Pioneering, ARCH Venture Partners, and Fidelity Management and Research Company. 

Edits on 7 Mar 2019
Golden AI
Golden AI edited on 7 Mar 2019 10:15 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 6 Mar 2019
Lourdelyn Cagadas
Lourdelyn Cagadas approved a suggestion from Golden's AI on 6 Mar 2019 12:55 am
Edits made to:
Infobox (+2 properties)
Lourdelyn Cagadas"Initial topic creation"
Lourdelyn Cagadas created this topic on 6 Mar 2019 12:55 am
Edits made to:
Topic thumbnail

 Codiak BioSciences

Codiak Biosciences is a biotechnology company developing exosome therapeutics.

No more activity to show.